Haploinsufficiency of the mouse Atp6v1b1 gene leads to a mild acid-base disturbance with implications for kidney stone disease. by Bourgeois, Soline et al.
Zurich Open Repository and
Archive
University of Zurich
Main Library
Strickhofstrasse 39
CH-8057 Zurich
www.zora.uzh.ch
Year: 2018
Haploinsufficiency of the mouse Atp6v1b1 gene leads to a mild acid-base
disturbance with implications for kidney stone disease.
Bourgeois, Soline; Bettoni, Carla; Baron, Stéphanie; Wagner, Carsten A
Abstract: BACKGROUND/AIMS: Homozygous mutations or deletion of the ATP6V1B1 gene encoding
for the B1 subunit of the vacuolar H+-ATPase leads to distal renal tubular acidosis in man and mice.
In humans, heterozygous carriers of B1 mutations can develop incomplete dRTA with nephroclacinosis.
Here, we investigated whether Atp6v1b1+/- mice also develop acid-base disturbances during an HCl acid
load. METHODS: We subjected Atp6v1b1+/+, Atp6v1b1+/-, Atp6v1b1-/- to an HCl-load for 7 days
and investigated acid-base status, kidney function, and expression of renal acid-base transport proteins.
RESULTS: Atp6v1b1-/- mice had more alkaline urine and low ammoniuria, whereas Atp6v1b1+/- mice
showed no difference in their urine parameters but higher blood chloride and lower blood pCO2 compared
to controls. Subcellular localization of a4 and B2 subunits of H+-ATPase were unchanged within the
3 genotypes and Atp6v1b1+/+ and Atp6v1b1+/- mice exhibited a similar luminal localization of B1
subunit in intercalated cells. However, B1, B2 and a4 expression were decreased in renal membrane
fractions from Atp6v1b1+/- mice compared to Atp6v1b1+/+ while B2 and a4 were unchanged and B1
protein was reduced in Atp6v1b+-/- kidneys. Compensatory mechanisms of B1 ablation were found
only in the collecting duct with a down-regulation of pendrin in Atp6v1b1-/- mice. CONCLUSIONS: In
conclusion, 1) Atp6v1b1+/- mice developed a mild incomplete dRTA. dRTA is partly compensated by
respiration. 2) Compensatory mechanisms for the absence of B1 take place only in the collecting duct of
Atp6v1b1-/- kidneys.
DOI: https://doi.org/10.1159/000490186
Posted at the Zurich Open Repository and Archive, University of Zurich
ZORA URL: https://doi.org/10.5167/uzh-152600
Journal Article
Published Version
 
 
Originally published at:
Bourgeois, Soline; Bettoni, Carla; Baron, Stéphanie; Wagner, Carsten A (2018). Haploinsufficiency of the
mouse Atp6v1b1 gene leads to a mild acid-base disturbance with implications for kidney stone disease.
Cellular Physiology and Biochemistry, 47(3):1095-1107.
DOI: https://doi.org/10.1159/000490186
Cell Physiol Biochem 2018;47:1095-1107
DOI: 10.1159/000490186
Published online: May 30, 2018 1095
Cellular Physiology 
and Biochemistry
© 2018 The Author(s). Published by S. Karger AG, Basel
www.karger.com/cpb
Bourgeois et al.: Phenotype of Atp6v1b1 Haploinsufficiency in Mice
Original Paper
Accepted: April 10, 2018
This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 Interna-
tional License (CC BY-NC-ND) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution 
for commercial purposes as well as any distribution of modified material requires written permission.
I: 0.1159/0 490186
lished online: May 30, 2018
© 2018 The Author(s) 
Published by S. Karger AG, Basel
www.karger.com/cpb
© 2018 The Author(s)
Published by S. Karger AG, Basel
Haploinsufficiency of the Mouse 
Atp6v1b1 Gene Leads to a Mild Acid-Base 
Disturbance with Implications for Kidney 
Stone Disease
Soline Bourgeoisa    Carla Bettonia    Stéphanie Baronb    Carsten A. Wagnera
aInstitute of Physiology, University of Zurich, Zurich, Switzerland, bHôpital Européen Georges Pompidou, 
Département de Physiologie, Assistance Publique-Hôpitaux de Paris, Paris, France
Key Words
Distal renal tubular acidosis • Heterozygosity • Collecting duct
Abstract
Background/Aims: Homozygous mutations or deletion of the ATP6V1B1 gene encoding 
for the B1 subunit of the vacuolar H+-ATPase leads to distal renal tubular acidosis in man 
and mice. In humans, heterozygous carriers of B1 mutations can develop incomplete dRTA 
with nephroclacinosis. Here, we investigated whether Atp6v1b1+/- mice also develop acid-
base disturbances during an HCl acid load. Methods: We subjected Atp6v1b1+/+, Atp6v1b1+/-, 
Atp6v1b1-/- to an HCl-load for 7 days and investigated acid-base status, kidney function, and 
expression of renal acid-base transport proteins. Results: Atp6v1b1-/- mice had more alkaline 
urine and low ammoniuria, whereas Atp6v1b1+/- mice showed no difference in their urine 
parameters but higher blood chloride and lower blood pCO2 compared to controls. Subcellular 
localization of a4 and B2 subunits of H+-ATPase were unchanged within the 3 genotypes 
and Atp6v1b1+/+ and Atp6v1b1+/- mice exhibited a similar luminal localization of B1 subunit 
in intercalated cells. However, B1, B2 and a4 expression were decreased in renal membrane 
fractions from Atp6v1b1+/- mice compared to Atp6v1b1+/+ while B2 and a4 were unchanged 
and B1 protein was reduced in Atp6v1b+-/- kidneys. Compensatory mechanisms of B1 ablation 
were found only in the collecting duct with a down-regulation of pendrin in Atp6v1b1-/- mice. 
Conclusions: In conclusion, 1) Atp6v1b1+/- mice developed a mild incomplete dRTA. dRTA is 
partly compensated by respiration. 2) Compensatory mechanisms for the absence of B1 take 
place only in the collecting duct of Atp6v1b1-/- kidneys.
IntroductionExtracellular pH has to be tightly kept in the normal physiologic range of pH 7.36-7.44 to maintain normal organ and body function. The kidney has a major role in controlling and maintaining systemic acid-base status by three intricately linked mechanisms: the 
reabsorption of filtered bicarbonate, the excretion of acids in the form of ammonium 
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and titratable acidity (mainly as phosphate), and the de novo generation of bicarbonate essentially during ammoniagenesis. The latter process allows the excretion of acids and the 
replenishing of bicarbonate used to buffer acids. The reabsorption of filtered bicarbonate is mostly achieved by the proximal tubule and to a lesser extent by the thick ascending limb 
and the distal convoluted tubule (for review, [1]). Under Western diet, an acid-producing 
diet, urine entering the connecting tubule contains only minute amounts of bicarbonate [1]. 
The ultimate fine-tuning of renal acid or base excretion takes place in the collecting system 
involving various cell types and distinct transport proteins. In the collecting system, acid-secretory type-A intercalated cells secrete protons via an apically located V-type H+-ATPase and generate new bicarbonate released by basolateral chloride/bicarbonate exchangers including the AE1 anion exchanger [2]. The V-type H+-ATPase is a multimeric protein 
complex with at least 16 subunits differentially expressed along the nephron [3]. In the 
kidney, the B1 subunit, part of the cytosolic V
1
 domain, is mostly expressed in the various 
types of intercalated cells of the collecting system (review [3, 4]).The importance of collecting duct acid-base excretion to overall systemic acid-base balance is highlighted by several rare inherited disorders affecting collecting duct acid-base 
transport proteins causing distal renal tubular acidosis (dRTA) (for review [5, 6]_ENREF_2). 
In man, mutations in the ATP6V1B1 gene lead to dRTA and sensorineural hearing loss and 
the disease is considered to be inherited in an autosomal recessive manner [7-9]. However, it has been shown recently in a kindred with a truncation mutation of ATP6V1B1,(p.
Phe468fsX487), that heterozygosity could lead to a mild incomplete dRTA with more alkaline 
urine and nephrocalcinosis [10]. In a follow-up study the authors investigated the role of the p.E161K variant in a cohort of stone formers and could show that heretozygous carriers 
exhibited a mild urinary acidification deficit with an increased prevalence of calcium-
phosphate kidney stones [11]. In mouse, total ablation of the Atp6v1b1 gene causes dRTA 
with a decrease in ammonium excretion and more alkaline urine pH [7]. However, the impact 
of haploinsufficiency on renal acid handling has never been investigated so far. Thus our aim was to determine whether Atp6v1b1 heterozygote mice also exhibit some features of dRTA 
in order to gain new insights whether haploinsufficiency may help explaining the occurrence of incomplete dRTA in carriers with monoallelic ATP6V1B1 mutations.
Materials and Methods
AnimalsGeneration and breeding of Atp6v1b1-/- mice has been previously described [19]. Experimental mice were generated by mating Atp6v1b1+/- mice. All experiments were performed with 6 to 7 months old 
littermate mice according to Swiss Animal Welfare laws and approved by the local veterinary authority (Veterinäramt Zürich).
In vivo experimentsAll experiments were performed using age- and sex-matched Atp6v1b1 wildtype (Atp6v1b1+/+), 
Atp6v1b1 knockout (Atp6v1b1-/-), and Atp6v1b1 heterozygote (Atp6v1b1+/-) littermate mice, housed in 
metabolic cages (Techniplast, Switzerland). Mice were given deionized water ad libitum and were fed with 
a standard powdered laboratory chow (Kliba, Augst, Switzerland) mixed with deionized water (a 50:75 
mixture (w/V)). Mice were allowed to adapt to metabolic cages for 3 days and a first retro-orbital blood 
sample was taken for blood gas analysis under baseline. Then two 24 hrs urine samples were collected 
under light mineral oil in the urine collector to determine daily urinary parameters. Mice were then allowed 
to recover for 2 weeks in normal cages. Metabolic acidosis was induced by diet (0.2 M HCl in standard 
powdered food) for 7 days. Food, water intake, and urine excretion was monitored following the same 
procedures as under baseline conditions. Urine collections were performed on the first and second day of 
acid-loading, and then on the sixth and seventh day. Retro-orbital blood samples were taken on the second 
and seventh day of the HCl diet.
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Analytic procedures
Blood pH, pCO
2
, and electrolytes were measured with a pH/blood-gas analyzer (ABL 77 Radiometer). 
Urinary Na+, Cl-, NH4+, K+, PO42+, Ca2+, creatinine and urea concentrations were determined on an UniCel DxC 
800 Synchron Clinical Systems (Beckman Coulter). Urine titratable acidity was measured in accordance with 
Jorgensen and Siggaard-Andersen [31, 32]. Briefly, CO
2
 was eliminated by hydrochloric acid addition. Then, 
titratable acidity was measured by sodium hydroxyde (1N) titration to pH 7.40 with DL 55 Mettler Toledo® 
titrator, ST20 Mettler® sample changer and Inlab® Semi micro pH electrode. Urinary pH was measured on 
fresh urine with a pHmeter. Citric acid was measured using a kit from Boehringer Mannheim/ R-Biopharm.
Immunohistochemistry
Seven day HCl loaded Atp6v1b1+/+, +/- and -/- mice were anesthetized with ketamine/xylazine and perfused through the left heart ventricle with a pre-fixative solution (1000 U/ml Heparin, 0.2% procain-HCl, 
3.2% CaCl
2
 and 0.18% NaCl) followed by the fixative (3% Paraformaldehyde (PFA)/PBS). After incubation 
in PFA/PBS for one hour, kidneys were placed overnight in 32% sucrose/PBS and subsequently embedded 
in OCT embedding Matrix (Cell Path, Newtown, Wales, United Kingdom) and frozen in liquid propane. 
Cryosections of 3 μm were mounted on slides (Superfrost Plus, Thermo Scientific). Autofluorescence from 
free aldehydes sites was quenched by incubation of the slides in a 50 mM NH4Cl/PBS solution during 20 
min. Sections were then treated with 1% SDS/PBS during 5 min, washed with PBS, and blocked with 1% 
bovine serum albumin/PBS. After blocking, sections were incubated with primary antibodies (guinea pig 
anti-AE1 1:500 [33], rabbit anti-a4 H+-ATPase 1:500 [34], rabbit anti-B1 H+-ATPase [34], rabbit anti-B2 H+-
ATPase 1:500 [35], and goat anti AQP-2 (Santa Cruz Biotechnology), 1:1000) diluted in PBS for incubation 
over night at 4°C. Then, samples were washed 3 times with PBS/NaCl (18g NaCl/PBS), and incubated with the secondary antibodies (donkey anti-rabbit 594, donkey anti-goat 488 and donkey anti-guinea pig 647 
(Molecular Probes) at 1:1000 and DAPI, 1:400) during 2 hours at room temperature. After three consecutive 
washing steps with PBS coverslips were mounted with Glycergel (DakoCytomation, Baar, Switzerland). 
Fluorescence was detected with a Leica fluorescence microscope.
Immunoblotting
Brush border membranes and total membrane fractions were obtained from 7-day HCl loaded 
Atp6v1b1+/+, +/- and -/- mouse kidneys. For total membrane preparations, frozen kidneys were homogenized 
in an ice-cold K-HEPES buffer (200 mM mannitol, 80 mM HEPES, 41 mM KOH, pH 7.5) containing a protease 
inhibitor mix (Complete Mini, Roche Diagnostics, Germany) at a final concentration of 1 tablet in a volume of 
10 ml solution. Samples were centrifuged at 2000 rpm for 20 min at 4°C. Subsequently, the supernatant was 
transferred to a new tube and centrifuged at 41’000 rpm for 1 h at 4°C. The resultant pellet was resuspended 
in K-HEPES buffer containing protease inhibitors. For brush border membrane preparations, frozen kidneys 
were homogenized in homogenization buffer (300 mM Mannitol, 5 mM EGTA, 12 mM Tris/HCl, pH 7.1) 
for 2 min on ice using a Polytron homogenizer (PT 10–35, Kinematica GmbH, Lucerne). The homogenates 
were then diluted in water (x1.4v/v) and MgCl
2
 was added at a final concentration of 12 mM. Brush border 
membranes were precipitated 15 min on ice and then centrifuged at 4500 rpm for 15min at 4°C. The pellet 
was resuspended in 300 mM Mannitol, 20 mM HEPES-Tris pH 7.4 solution and centrifuged at 18000 rpm for 
30 min at 4°C. The pellet was resuspended and kept at 80°C. Protein concentrations were determined with 
the BioRad DC protein assay, based on the Lowry method (Bio-Rad, Hercules, CA, USA) [36].
Up to fourty micrograms of total membrane proteins or brush border membranes were solubilized 
in Laemmli loading buffer containing 10% DTT and separated on 8 to 10% polyacrylamide gels. For 
immunoblotting, proteins were transferred electrophoretically to polyvinylidene fluoride membranes 
(Immobilon-P, Millipore Corp., Bedford, MA, USA). After blocking with 5 % milk powder in Tris-buffered 
saline/0.1% Tween-20 for 60 min, blots were incubated with primary antibodies: rabbit anti-mouse 
Atp6v1b1 (B1) (1:5, 000) [37], rabbit anti-ATP6v1b2 (B2) (1:5, 000) [35], rabbit anti-ATP6v0a4 [34], (1:5, 
000), rabbit anti- ATP6v1A 1:2, 000, rabbit anti-pendrin (1:2, 000) [29], rabbit anti-AE1 (1:2, 000) [33], 
rabbit anti-AQP2 (1:2, 000) and rabbit anti-NKCC2 (1:5, 000) (kind gift of J. Loffing, University of Zurich) 
[38], rabbit anti-NBCe1 (1:1, 500) (Proteintech, United Kingdom), rabbit anti-NHE3 (1:2, 000) (StressMarq 
Biosciences, Inc, Victoria, British Columbia) and mouse monoclonal anti-β-actin antibody (Sigma, St. 
Louis, MO; 1:20, 000) overnight at 4°C. After washing and blocking with 5 % milk powder for 60 min, 
membranes were incubated for 2 h at room temperature with secondary goat anti-rabbit or donkey anti-
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mouse antibodies 1:5, 000 linked to alkaline phosphatase (Promega, Madison, WI, USA). The protein signal 
was detected with the appropriate substrate (Millipore Corp, Bedford, MA, USA) using the las-4000 image 
analyzer system (Fujifilm Life Science USA). All images were analyzed using Advanced Image Data Analyzer 
AIDA (Raytest, Straubenhardt, Germany) to calculate the protein of interest/β-actin ratio.
Statistics
Data are shown as means ± SEM. Comparisons between experimental conditions were performed 
using non parametric ANOVA (Kruskal-Wallis test) or one-way ANOVA of variance with Bonferroni test. P 
values of ≤ 0.05 were chosen to indicate statistical significance.
Results
Atp6v1b1 heterozygous mice exhibit no overt dRTA but develop an intermediate phenotype 
compared to knockout and wildtype animals
We first assessed acid-base status under basal conditions and during an acid load in Atp6v1b1 wildtype, heterozygote or homozygote littermates. Throughout the study, 
food intake was similar in all three genotypes. At baseline, no difference in acid-base and 
electrolyte levels was observed (Tables 1 and 2). The effects of both acute (2 days) and 
chronic (7 days) HCl loading were tested (Tables 1 - 3, Fig. 1 and 2).
On the second day of the HCl load, blood pH was not different between the 3 strains of 
mice. In contrast, blood pCO
2
 was drastically reduced after 2 days of HCl-loading and despite 
some recovery remained significantly lower in heterozygous mice (Table 1). Blood HCO3- 
concentration was decreased by HCl-loading after 2 days of treatment in all genotypes as 
compared with baseline (Table 1, Fig. 1C) which was paralleled by an increase in blood Cl- (Fig. 
1D, Table 1). However, after 7 days of HCl-loading, blood HCO3- and pH were not different to baseline anymore in Atp6v1b1+/+ indicating normal adaptation of the kidney to the acid load but remained lower both in Atp6v1b1+/- and Atp6v1b1-/-. Moreover, blood Cl- concentration 
was significantly  higher in Atp6v1b1-/- and  Atp6v1b1+/- and than in Atp6v1b1+/+ consistent with varying degrees of metabolic acidosis in Atp6v1b1+/- and Atp6v1b1-/- mice.
Urinary pH was more alkaline in Atp6v1b1-/- at baseline and remained more alkaline 
throughout the entire acid-loading period (Fig. 2, Tables 1-3). Similarly, urinary ammonium excretion was lower in Atp6v1b1-/- mice after 2, 6 and 7 days of HCl acid-loading demonstrating 
incomplete dRTA with reduced urinary acid excretion. After 7 days of HCl loading, Atp6v1b1-/- mice had developed a nearly 3 fold lower net acid excretion compared to Atp6v1b1+/+ (Tables 
Table 1. Blood values in Atp6v1b1+/+, Atp6v1b1+/-, and Atp6v1b1-/- littermate mice under normal diet and 
during an acid load. Values are mean ± SEM, * p<0.05 vs baseline period in same genotype, # p<0.05 vs 
Atp6v1b1+/+ mice   Basal status 2 days HCl 7 days HCl 
 Atp6v1b1+/+ N = 5 Atp6v1b1+/- N = 9 Atp6v1b1-/- N = 8 Atp6v1b1+/+ N = 5 Atp6v1b1+/- N = 9 Atp6v1b1-/- N = 9 Atp6v1b1+/+ N =6 Atp6v1b1+/- N = 9 Atp6v1b1-/- N = 9 pH 7.24  ± 0.06 7.34  ± 0.01 7.26  ± 0.04 7.15  ± 0.05 7.16  ± 0.05* 7.21  ± 0.02 7.23  ± 0.02 7.19  ± 0.03* 6.99  ± 0.12* pCO2 (mmHg) 41.1  ± 1.9 39.9  ± 1.4 40.7  ± 0.9 34.6  ± 0.8* 33.0  ± 1.1* 34.2  ± 1.1* 46.1  ± 1.3 40.6  ± 0.86# 43.7  ± 2.7 HCO3 (mM) 20.0 ± 1.6 21.2  ± 0.8 18.8  ± 1.2 12.1  ± 1.5* 12.0  ± 1.3* 13.4  ± 1.0* 18.7  ± 0.8 15.5  ± 1.20* 12.3  ± 2.2*# pO2 58.5 ± 3.0 52.7  ± 2.8 57.0  ± 1.8 68.8 ± 2.2* 66.6 ± 2.8* 64.3 ± 2.4* 54.2 ± 2.1 65.9 ± 4.58 88.9 ± 10.8*# Na (mM) 148.2 ± 0.6 146.8 ± 0.8 147.7 ± 0.3 149.8 ± 0,3 149.9 ± 1.0 149.3 ± 0.5 151.8 ± 0.4 153.0 ± 0.7* 152.2 ± 1.3* Cl (mM) 115.0  ± 0.6 112.1  ± 1.4 115.2 ± 0.7 126.5  ± 1.6* 127.3 ± 1.5* 122.9 ± 1.2* 118.0 ± 0.7 124.1 ± 1.5*# 130.9  ± 4.2*# Ca (mM) 1.25 ± 0.01 1.21 ± 0.01 1.24 ± 0.01 1.30 ± 0.01* 1.34 ± 0.03* 1.35 ± 0.02* 1.31 ± 0.01* 1.31 ± 0.01* 1.58 ± 0.14* Urea (mM) ND ND ND ND ND ND 9.13 ± 0.71 8.5 ± 0.8 7.5 ± 0.6 Hematocrit (%) 44.8  ± 0.5 44.8  ± 0.7 42.5  ± 1.6 45.5  ± 0.7 44.6  ± 1.0 45.2  ± 1.0 47.4  ± 0.8* 45.9  ± 1.3 49.5  ± 1.2* Na-Cl (mM) 33.2 ± 0.7 34.7  ± 1.0 32.4 ± 0.6 23.3 ± 1.3* 22.6 ± 1.8* 26.4 ± 1.1* 33.7  ± 0.8 28.9  ± 1.2* 21.3  ± 4.5*#  
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2 - 3 and Fig. 2). Atp6v1b1+/- mice exhibited an intermediate phenotype between Atp6v1b1+/+ 
and Atp6v1b1-/- with reduced urinary ammonium and net acid excretion (Tables 2 - 3 and 
Fig. 2) which however did not reach statistical significance when compared to Atp6v1b1+/+. 
Patients with biallelic ATP6V1B1 mutations frequently develop nephrocalcinosis [9, 11, 
12] and nephrocalcinosis has been also reported in some patients with only monoallelic 
ATP6V1B1 mutations [10, 11]. We thus tested whether urinary calcium, phosphate and citrate excretion were different between genotypes and found no obvious difference at any 
of the time points tested (Tables 1 - 3).
The subcellular localization of H+-ATPase subunits is similar in Atp6v1b1+/+, Atp6v1b+/-, 
and Atp6v1b-/- mice
We performed immunostainings for the B1, B2 and a4 subunits of the V-type H+-ATPase 
(Fig. 3). In order to examine only H+-ATPase complexes in acid-secretory type A intercalated 
cells, we costained for the anion exchanger 1 (AE1) which is specifically expressed in 
type A intercalated cells [13]. As expected, the B1 subunit was not detected in kidneys from Atp6v1b1-/- mice but its expression and localization was preserved in kidneys from 
Table 2. Body weight, food and water intake, and urinary values in Atp6v1b1+/+, Atp6v1b1+/-, and Atp6v1b1-/- 
littermate mice littermates during 2 and 6 days of HCl loading reported to creatinine excretion. TA titratable 
acid; Values are mean ± SEM. * p<0.05 vs baseline period in same genotype, # p<0.05 vs Atp6v1b1+/+ mice 
 2 days HCl 6 days HCl  Atp6v1b1+/+ Atp6v1b1+/- Atp6v1b1-/- Atp6v1b1+/+ Atp6v1b1+/- Atp6v1b1-/- (N=15 to 17) (N=15 to 23) (N=16 to 17) (N=7 to 17) (N=11 to 23) (N=9 to 17) Metabolic values       Weight (g) 28.7  ± 1.3* 28.6  ± 1.0* 27.9  ± 1.4* 28.4  ± 0.8* 28.1  ± 0.7* 24.0  ± 0.9*# Food intake (g/24hrs/body weight) 0.17  ± 0.01 0.20  ± 0.02 0.12  0.02 0.20  ± 0.02 0.23  ± 0.01 0.22  ± 0.03 Water intake (ml/24h) 4.16  ± 1.16 3.45   ± 0.58 4.20   ± 0.64 5.73  ± 1.75 4.22   ± 0.55 6.26  ± 1.15 Urine values         Volume (ml/24 h) 2 98  ± 0.37 3.01  ± 0.35 2..54  ± 0.33 4.70  ± 1.04 4.45  ± 0.46 3.59  ± 0.55 Creatinine (mM) 3.96  ± 0.33 3.85  ± 0.64 3.45  ± 0.37 2.61  ± 0.22 1.98  ± 0.27 2.59  ± 0.85 Urinary pH 5.70 ± 0.07* 5.62 ± 0.06* 6.11 ± 0.08*# 5.89  ± 0.16* 5.74 ± 0.04* 6.37 ± 0.07*# NH4/Crea (mEq/mmol) 107.7  ± 14.6* 129.2  ± 15.6* 59.1  ± 4.8*# 236.9 ± 19.0* 194.6  ± 18.6* 113.9 ± 6.5*# Pi/Crea (mEq/mmol) 4.6  ± 0.3 4.7 ± 0.2 5.4 ± 0.4 ND ND ND Citric acid/Crea (mEq/mmol) 0.043 ± 0.02 0.07 ± 0.01 0.10 ± 0.02 ND ND ND Ca/Crea (mEq/mmol) 4.03  ± 0.63* 4.00  ± 0.52* 2.43  ± 0.36*# ND ND ND Urea/Crea (mg/mmol) 321.1  ± 11.8 335.2  ± 23.6 283.2  ± 11.3 ND ND ND Na/Crea (mEq/mmol) 15.7  ± 2.1 17.3  ± 2.3 14.2  ± 3.5 ND ND ND Cl/Crea (mEq/mmol) 116.8  ± 11.7* 131.4  ± 20.2* 63.4  ± 16.6 ND ND ND K/Crea (mEq/mmol) 45.6  ± 4.1 47.1  ± 4.8 34.3 ± 5.6 ND ND ND  
Table 3. Body weight, food and water intake, and urinary values in Atp6v1b1+/+, Atp6v1b1+/-, and Atp6v1b1-/- 
littermate mice at baseline and after 7 days of HCl load reported to creatinine excretion, TA titratable acid; 
Values are mean ± SEM. * p<0.05 vs baseline period in same genotype, # p<0.05 vs Atp6v1b1+/+ mice 
 Basal status 7 days HCl Atp6v1b1+/+ Atp6v1b1+/- Atp6v1b1-/- Atp6v1b1+/+ Atp6v1b1+/- Atp6v1b1-/- (N=11 to 17) (N=11 to 23) (N=5 to 17) (N=7 to 17) (N=11 to 23) (N=7 to 17) Metabolic values       Weight (g) 31.6  ± 1.3 30.9  ± 0.9 30.5  ± 1.4 27.5  ± 0.9* 27.2  ± 0.7* 23.9  ± 0.9*# Food intake (g/24h/body weight) 0.21  ± 0.02 0.26  ± 0.02 0.27  ± 0.02 0.24  ± 0.02 0.25  ± 0.02 0.22  ± 0.04 Water intake (ml/24h) 1.71  ± 0.19 1.53  ± 0.17 1.34  ± 0.16 6.20  ± 1.75* 4.14  ± 0.56* 4.19  ± 0.81* Urine values         Volume (ml/24h) 1.90  ± 0.22 1.89  ± 0.17 1.95  ± 0.20 3.95  ± 0.77 3.96  ± 0.46 1.81  ± 0.44 Creatinine (mM) 3.45  ± 0.37 2.94  ± 0.31 3.23 ± 0.45 3.31± 0.44 2.28  ± 0.33 3.48  ± 1.01 Urinary pH 6.13 ± 0.06 6.18 ± 0.06 6.52 ± 0.08# 5.85  ± 0.20* 5.72  ± 0.05* 6.34  ± 0.09*# NH4/Crea (mEq/mmol) 12.8 ± 2.3 14.6  ± 2.3 10.4 ± 1.1 143.6  ± 18.2* 138.7  ± 10.15* 89.9  ± 8.6*# TA/Crea (mEq/mmol) ND ND ND 7.6  ± 2.1 11.2 ± 1.9 5.2  ± 1.9# Pi/Crea (mEq/mmol) 6.7  ± 0.5 7.0  ± 0.5 6.31 ± 030 5.6  ± 0.4* 5.1  ± 0.3* 4.4  ± 0.5* Citric acid/Crea (mEq/mmol) 0.25 ± 0.11 0.38 ± 0.17 0.27 ± 0.06 0.075 ± 0.02 0.10 ± 0.02 0.09 ± 0.02 Net Acid/Crea (mEq/mmol) ND ND ND 151.3  ± 18.6 149.9  ± 9.8 95.1  ± 10.1# Ca/Crea (mEq/mmol) 0.35  ± 0.07 0.43  ± 0.09 0.23  ± 0.03 4.85  ± 0.78 3.89  ± 0.57 4.80  ± 0.86 Urea/Crea (mEq/mmol) 285.8  ± 23.0 318.3  ± 20.1 361.2  ± 15.0 398.3  ± 18.8 391.5  ± 18.5 437.8  ± 38.5 Na/Crea (mEq/mmol) 13.5  ± 1.7 14.9  ± 1.5 17.6  ± 1.7 25.7  ± 3.9 29.9  ± 4.2 22.0  ± 6.7 Cl/Crea (mEq/mmol) 29.3  ± 3.2 34.6  ± 2.6 34.4  ± 3.5 172.0  ± 28.6* 201.6  ± 23.7* 115.6  ± 47.8* K/Crea (mEq/mmol) 46.1  ± 7.6 59.7  ± 4.3 58.8  ± 5.3 64.3  ± 7.9 72.4  ± 6.4 47.2  ± 15.0 
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Atp6v1b1+/- mice. The apparent localization of B2 and a4 H+-ATPase subunits at the apical pole of type A intercalated cells was similar in all genotypes.
Expression of H+-ATPase subunits from the V0 and 
V1 domains is reduced in Atp6v1b1+/- kidneysImmunoblots on proteins enriched for apical membranes and on total membrane proteins isolated from kidneys of 7 day acid-loaded Atp6v1b1+/+, 
Atp6v1b1+/-, and Atp6v1b1-/- mice were performed 
assessing the abundance of the B1, B2, a4 and A H+-ATPase subunits belonging to the V
1
 and V
0
 domains 
(Fig. 4 and 5). B1 protein which is mostly expressed in intercalated cells of collecting duct could be detected in apical membranes from Atp6v1b1+/+ and Atp6v1b1+/- and was completely absent from the kidney tissue of 
Atp6v1b1-/- (Fig. 4A and 5A). However, the relative abundance was unchanged in apical membranes from Atp6v1b1+/+ and Atp6v1b1+/- (Fig. 4A) whereas it was clearly reduced in total membranes from 
Atp6v1b1+/- as compared to Atp6v1b1+/+ (Fig. 5A) suggesting redistribution to the apical membrane 
in heterozygous animals. In contrast, the relative 
abundance of the B2, A and a4 H+-ATPase subunits in the apical membrane preparation was similar in 
Fig. 2. Urinary pH, ammonia, and net 
acid excretion in Atp6v1b1 littermate 
mice. Atp6v1b1+/+(⧳), Atp6v1b1+/-(⧮), and Atp6v1b1-/- (⧲) mice were observed in metabolic cages under basal condi-
tions and during HCl acid loading for 7 days (shaded area). A) Urinary pH, B) 
Urinary NH4+ normalized to urinary cre-
atinine at day 7 of the HCl challenge, C) 
Net acid excretion (NAE) after 7 days HCl 
loading. *p ≤ 0.05, **p ≤ 0.1
Fig. 1. Systemic acid-base parameters in Atp6v1b1 littermate 
mice during an HCl load. Blood parameters were measured in 
Atp6v1b1+/+ (⧳), Atp6v1b1+/- (⧮), and Atp6v1b1-/-(⧲) mice be-
fore and during a 7 day HCl load (shaded area). A) Blood pH, 
B) blood pCO
2
, C) blood bicarbonate and D), blood Cl-. *p ≤ 0.05
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Fig. 3. Subcellular localization of H+-ATPases in type A-intercalated cells is similar in Atp6v1b1+/+, Atp6v1b1+/-, and Atp6v1b1-/- mice. Kidney sections from Atp6v1b1+/+, Atp6v1b1+/-, and Atp6v1b1-/- for 7 days were stained 
for the B1, B2 and a4 H+-ATPase subunits (in red), the anion exchanger AE1 (green) as a marker for type A 
intercalated cells, and for the water channel AQP2 (blue) as a marker for principal cells. Original magnifica-
tion 400 x, inserts show higher magnification of single intercalated cells.
Fig. 4. Protein abundance of the 
B1, B2, a4 and A H+-ATPase sub-units in apical kidney membranes from acid-loaded Atp6v1b1+/+, At-
p6v1b1+/-, and Atp6v1b1-/- mice. Proteins enriched from apical membranes were isolated from kidneys of Atp6v1b1+/+ (black), 
Atp6v1b1+/-(grey), and Atp6v1b1-/- (white) acid-loaded for 7 days. All immunoblot membranes were 
probed for β-actin to control for 
loading. Bar graphs summarize 
the ratio of specific H+-ATPase sub-
units over β-actin. A) B1 H+-ATPase 
subunit, B), B2 H+-ATPase subunit, 
C) a4 H+-ATPase subunit, and D) A H+-ATPase subunit. Values are 
mean ± SEM (n= 5 or 6 mice), ***p 
≤ 0.001.
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all three genotypes (Fig. 4B-D). In total membrane 
preparations, reduced abundance of the B2 and a4 H+-ATPase subunits in Atp6v1b1+/- kidneys were 
observed (Fig. 5B-D). Interestingly, in Atp6v1b1-/- kidneys no difference in the abundance of these subunits was detected.
Compensatory mechanisms involved in acid 
handling by the kidneyTo assess whether compensatory mechanisms in the kidney could explain the very mild defect in Atp6v1b1+/- mice during the acid challenge, we performed immunoblots for some key proteins involved in ammonia and bicarbonate transport 
in the proximal tubule, thick ascending limb, and 
the distal nephron (late distal tubule, connecting 
tubule and collecting duct). No obvious regulation was detected for the sodium-proton exchanger 
isoform 3 (NHE3) and the electrogenic sodium-
bicarbonate cotransporter NBCe1, both involved in 
proximal tubular bicarbonate reasbsorption. Also, the Na+/K+/2Cl- -cotransporter NKCC2, 
Fig. 6. Protein abundance of NBCe1, NHE3 
and NKCC2 in total kidney membrane frac-tions from acid-loaded Atp6v1b1+/+, At-
p6v1b1+/-, and Atp6v1b1-/- mice. Total mem-brane proteins were isolated from kidneys of Atp6v1b1+/+ (black), Atp6v1b1+/- (grey), and Atp6v1b1-/- (white) acid-loaded for 7 days. All immunoblot membranes were 
probed for β-actin to control for loading. 
Bar graphs summarize the ratio of specific 
proteins over β-actin. A) NBCe1, B) NHE3, 
and C) NKCC2. Values are mean ± SEM (n= 
5 or 6 mice).
Fig. 5. Expression of the B1, B2, a4 and A H+-ATPase subunits in total kidney membrane fractions from acid-loaded At-
p6v1b1+/+, Atp6v1b1+/-, and Atp6v1b1-/-  mice. Total membrane proteins were isolated from kidneys of Atp6v1b1+/+ (black), 
Atp6v1b1+/- (grey), and Atp6v1b1-/- (white) acid-loaded for 7 
days. All immunoblot membranes were probed for β-actin to 
control for loading. Bar graphs summarize the ratio of specific 
H+-ATPase subunits over β-actin. A) B1 H+-ATPase subunit, 
B), B2 H+-ATPase subunit, C) a4 H+-ATPase subunit, and D) A H+-ATPase subunit. Values are mean ± SEM (n= 5 or 6 mice), * 
p ≤ 0.05, ***p ≤ 0.001.
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involved in renal ammonium handling, was unaltered (Fig. 6). The abundance of the type A 
intercalated specific anion exchanger as well as the expression of the AQP2 water channel 
was not different between genotypes (Fig. 7A and C). In contrast, the expression of the type 
B intercalated cell specific anion exchanger pendrin, involved in bicarbonate secretion into 
urine, was strongly downregulated in kidneys from Atp6v1b1-/- mice but unaltered in kidneys from Atp6v1b1+/- mice (Fig. 7B).
Discussion
Loss of the B1 or a4 H+-ATPase subunits in human causes congenital autosomal recessive 
dRTA with sensorineural deafness [6, 9, 12, 14-16]. Similarly, ablation of the Atp6v1b1 or 
Atp6v0a4 genes in mice causes dRTA [17-20]. In both species, the absence of functional 
B1 or a4 H+-ATPase subunits can be associated with the development of nephrocalcinosis 
or –lithiasis [6, 9, 12, 14, 16, 17, 21]. Moreover, recent studies described that monoallelic 
mutations in these 2 genes can also lead to urinary acidification defects with elevated risk 
for nephrocalcinosis or-lithiasis [10, 11, 22]. Along this line, a recent study investigated the ability of Atp6v0a4 heterozygous mice regarding to handle a chronic acid load. The authors showed that these mice were totally normal when not challenged but developed an 
incomplete dRTA with alkaline urine during a chronic NH4Cl load and exhibited a decrease in 
their bone mineralo-densitometry [17]. Whether heterozygous Atp6v1b1 mice had a similar 
problem to respond to a chronic acid load had remained unknown. Thus, our aims were to 
determine whether the heterozygous Atp6v1b1 mice would exhibit an acid handling deficit 
and study possible compensatory mechanisms to haploinsufficiency.
Fig. 7. Expression of AE1, 
pendrin and AQP2 in total kidney membrane frac-tions from acid-loaded 
Atp6v1b1+/+, Atp6v1b1+/-, and Atp6v1b1-/- mice. Total membrane proteins were isolated from kidneys of Atp6v1b1+/+ (black), 
Atp6v1b1+/- (grey), and 
Atp6v1b1-/- (white) acid-loaded for 7 days. All im-munoblot membranes 
were probed for β-actin 
to control for loading. Bar 
graphs summarize the 
ratio of specific proteins 
over β-actin. A) AE1, B), 
pendrin, and C) AQP2. Val-
ues are mean ± SEM (n= 5 
or 6 mice), * p ≤ 0.05, **p 
≤ 0.01.
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Haploinsufficiency in the mouse Atp6v1b1 gene leads to a mild acid-base disturbanceIn contrast to Atp6v1b1-/- mice which have more alkaline urine already at baseline 
and develop an overt severe metabolic acidosis during the acid challenge, Atp1b1+/- mice 
had no apparent defect at baseline and exhibited only a very mild deficit in acid handling 
during the HCl load. Indeed, at the end of the treatment, Atp6v1b1+/- mice had nearly similar net acid excretion rates than Atp6v1b1+/+ mice. However, at the same time blood chloride 
levels was significantly higher than in Atp1b1+/+ mice and blood pCO
2
 was lower. Since the 
measurement of blood gas status in mice is technically challenging, blood chloride levels are 
likely the most stable parameter indicating a mild metabolic acidosis in heterozygous mice. 
This increase in blood Cl- concentration both in heterozygous and KO mice cannot be linked to dehydration as hematocrit levels were not different between the three strains of mice. 
Moreover, the calculated sodium-chloride difference, an index for metabolic acidosis versus 
dehydration [23] showed a significant lower value in KO mice compared to WT mice at the 
end of the acid load and an intermediate but not significant value for heterozygous animals. 
Once again, this may indicate an acid-base disturbance.Finally, the  low pCO
2
 may point to a partial respiratory compensation. This very mild phenotype has also been observed in 
humans with heterozygous mutations in the B1 or a4 H+-ATPase subunits [10, 22] as well as in Atp6v0a4+/- mice [17]. While Atp6v0a4-/- mice develop severe spontaneous metabolic 
acidosis with high mortality before weaning, Atp6v0a4+/- mice exhibit no phenotype under 
control diet. However, Atp6v0a4+/- mice developed acidosis during a prolonged chronic acid 
load (at least 2 weeks of treatment). Here, we performed only 7 days of HCl load which may 
explain why we could not detect a more pronounced deficit in acid handling.
Contrary to the phenotype of human heterozygous ATP6V1B1 mutation carriers [10, 
11], we were not able to detect any abnormality in urinary citrate or calcium excretion in 
Atp6v1b1+/- mice.
Haploinsufficiency and dRTAAn increasing number of human case reports as well as studies in rodent models suggests that an incomplete from of dRTA can be associated to or caused by monoallelic 
mutations or haploinsufficiency of the ATP6V1B1 and ATP6V0A4 genes [10, 11, 17, 18, 22]. 
Similarly, hapoloinsufficiency of the Rhcg ammonia channel can also cause a mild form of 
dRTA in rodents [24]. However, the mechanisms causing dRTA may be different in patients with monoallelic mutations and in rodents with deletion of one allele. The major difference 
may be that the mutated B1 or a4 protein may even assemble into the whole pump complex 
and then impair its proper function. Since pumps contain 3 copies of the B1 protein and one 
copy of the a4 protein, particularly in the case of B1 mutations, integration of one, two or even three defective copies into the pump may be possible with varying degrees of impairment. 
Indeed, defective pump activity has been shown for many B1 mutations including some found 
in patients with incomplete dRTA and only monoallelic mutations [10, 11, 25]. In contrast, 
the incomplete dRTA seen in heterozygous Atp6v0a4 mice or in our Atp6v1b1 model may result from a gene dosage effect where less functional pumps can be formed due to reduced 
availability of a4 or B1 subunits. In our mouse model, a reduced abundance of the B1 protein 
was detected in heterozygous mice whereas no evidence was detected that trafficking of pumps to the apical pole of type A intercalated cells was severely impaired.
Renal adaptation to the reduced B1 protein expression
Immunoblotting showed that the reduced availability of B1 subunits at the luminal membrane in the Atp6v1b1+/- mice was associated also with a reduction in the a4 and B2 
subunits. Reduced abundance of B2 is surprising as we have shown previously that B2 
partly compensates for the loss of B1 in homozygous Atp6v1b1 KO mice [26]. However, no 
difference in total B2 protein had been detectable but a clear shift of B2 protein from an 
intracellular compartment to the luminal membrane [26]. More recently, the B1 KO mouse 
model was crossed with a mouse model expressing EGFP in intercalated cells allowing to 
purify them and to assess the expression of the various subunits on a purified population 
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of collecting duct intercalated cells [27]. The up-regulation of the B2 subunit was confirmed 
but also a downregulation of the A, E1, H and a4 subunits were documented. This finding is in accordance with the overall reduction in H+-ATPase activity in the Atp6v1b1-/- mice [19, 20, 
26, 28]. Thus, the mechanism how haploinsufficiency of the B1 protein can cause reduced a4 
and B2 protein expression remains unclear.
We further examined whether compensatory mechanisms in the transport of NH4+ and 
HCO3- in the proximal nephron and the collecting duct intercalated cells would contribute to the observed mild phenotype in Atp6v1b1+/-. We could not detect any change in the 
mechanisms located in the proximal nephron but found a 2-fold decrease in the expression of pendrin in Atp6v1b1-/- kidneys. Reduction of pendrin expression has already been described in a mouse model of Atp6v0a4-/- [18]. The authors had explained this down-regulation by 
the fact that excretion of HCO3- by the pendrin exchanger would be counterproductive in 
the presence of metabolic acidosis. Indeed, metabolic acidosis triggers downregulation of 
pendrin also in normal mice [29, 30] and the downregulation of pendrin in Atp6v1b1-/- mice may also prevent a further aggravation of metabolic acidosis.
Taken together, we show that haploinsufficiency in Atp6v1b1 mice led to a mild defect in 
renal acid excretion. Reduced expression of the B1 H+-ATPase subunit causes downregulation 
of the B2, and a4 H+-ATPase subunits. This phenotype is in agreement with the mild deficit 
in acid handling which was observed in human studies with patients heterozygous of 
ATP6V1B1 mutations and may provide some explanations for the disease mechanism.
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